Not applicableEnded earlyNCT05315908What this trial is testingCOVID-19 Testing in Underserved and Vulnerable PopulationsWho this might be right forHeart FailureCoronary Artery DiseaseCancer+5 more Jesse Nodora 9,120
Not applicableNot Yet RecruitingNCT07657455What this trial is testingDaily Versus Alternate-Day Oral Iron Therapy for Anemia in Second-Trimester PregnancyWho this might be right forIron Deficiency AnemiaAnemia in Pregnancy Pakistan Air Force (PAF) Hospital Islamabad 184
Not applicableStudy completedNCT00211068What this trial is testingRisk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin AlfaWho this might be right forPure Red-cell Aplasia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 124
Post-approval studies (Phase 4)UnknownNCT05921968What this trial is testingEffect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of AnemiaWho this might be right forIron Deficiency Anemia Ain Shams University 100
Not applicableLooking for participantsNCT03217656What this trial is testingThe Jiaxing Birth Cohort in ChinaWho this might be right forChildhood ObesityAnemiaPregnancy Complications+2 more Zhejiang University 500,000
Not applicableUnknownNCT04016922What this trial is testingThe Effect of Maternal Iron Deficiency Anemia on Fetal Hemodynamic and Neonatal OutcomeWho this might be right forFetal Conditions Cairo University 500
Post-approval studies (Phase 4)Study completedNCT03236246What this trial is testingKRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)Who this might be right forChronic Kidney DiseasesIron Deficiency Anemia Keryx Biopharmaceuticals 206
Early research (Phase 1)Study completedNCT01286987What this trial is testingStudy of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsWho this might be right forAdvanced or Recurrent Solid TumorsBreast NeoplasmsOvarian Cancer, Epithelial+4 more Pfizer 113
Large-scale testing (Phase 3)Study completedNCT04012957What this trial is testingDesidustat in the Treatment of Anemia in CKDWho this might be right forChronic Kidney Disease Stage 3AnemiaChronic Kidney Disease Stage 4+1 more Zydus Lifesciences Limited 588
Post-approval studies (Phase 4)Study completedNCT00111995What this trial is testingEvaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving HemodialysisWho this might be right forChronic Renal FailureAnemia Amgen 400
Post-approval studies (Phase 4)Ended earlyNCT01817699What this trial is testingCorrecting Anemia and Native Vitamin D Supplementation in Kidney Transplant RecipientsWho this might be right forKidney TransplantationAnemiaVitamin D Deficiency+1 more CANDLE-KIT Trial Study Group 161
Large-scale testing (Phase 3)Study completedNCT00121602What this trial is testingEfficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney DiseaseWho this might be right forAnemiaKidney Disease Amgen 446
Large-scale testing (Phase 3)Study completedNCT00597584What this trial is testingSafety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on HemodialysisWho this might be right forChronic Renal FailureChronic Kidney DiseaseAnemia Affymax 823
Post-approval studies (Phase 4)Study completedNCT00028093What this trial is testingPegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney DiseaseWho this might be right forChronic Hepatitis C National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Large-scale testing (Phase 3)Study completedNCT01887600What this trial is testingRoxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring DialysisWho this might be right forAnemia in Chronic Kidney Disease in Non-dialysis Patients Astellas Pharma Europe B.V. 594
Not applicableStudy completedNCT05699109What this trial is testingErythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis PatientsWho this might be right forAnemia of Chronic Kidney DiseaseChronic Renal FailureChronic Renal Failure Anemia Helwan University 127
Not applicableStudy completedNCT02136563What this trial is testingRenal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating AgentsWho this might be right forRenal AnemiaChronic Kidney Disease Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2,000
Large-scale testing (Phase 3)Study completedNCT03408639What this trial is testingComparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis PatientsWho this might be right forAnemia in End-Stage Renal Disease Cinnagen 156
Not applicableUnknownNCT04205123What this trial is testingBiological, Genetic and Environmental Involved in the Complications of Sickle Cell DiseaseWho this might be right forSickle Cell Disease Erasme University Hospital 200
Large-scale testing (Phase 3)Study completedNCT02021318What this trial is testingRoxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin AlfaWho this might be right forAnemia in Chronic Kidney Disease in Non-dialysis Patients Astellas Pharma Europe B.V. 616